PT 141 (Bremelanotide)
Typical Dosing Protocols (Research/Compounded Use Only) – PT-141 (Bremelanotide)
Common protocol: 0.5–2 mg subcutaneously as needed, injected 45–90 minutes before sexual activity. Most users start with 0.5–1 mg and titrate based on individual response.
Other reported ranges:
Standard: 1–2 mg per dose
Lower: 0.5 mg per dose (for beginners or sensitivity)
Frequency: Maximum 2–3 times per week to avoid desensitization.
Effects typically last 24–36 hours.
Reconstitution example (for a typical 10 mg vial): Add 2 mL bacteriostatic water (yielding ~5 mg/mL).
1 mg = 0.2 mL (20 units on U-100 insulin syringe)
2 mg = 0.4 mL (40 units)
Administration: Subcutaneous injection (abdomen or thigh).
Dosing is highly individualized based on goals (libido, arousal, sexual dysfunction) and response—consult a qualified healthcare provider experienced with peptides for personalized guidance. This is for informational purposes only.
Key Potential Benefits of PT-141 (Bremelanotide)
Powerful Stimulation of Sexual Desire and Libido
Directly activates melanocortin receptors (primarily MC4R) in the central nervous system to increase sexual motivation and arousal.
Boosts libido and spontaneous sexual desire in both men and women, often independent of visual or physical stimuli.
Provides a strong pro-sexual effect that works through the brain rather than vascular mechanisms.
Enhanced Sexual Arousal and Performance
Improves sexual arousal, genital sensitivity, and overall responsiveness during intimate activity.
Increases erection quality, rigidity, and duration in men, while enhancing lubrication and sensation in women.
Supports more satisfying sexual experiences with faster onset of arousal and heightened pleasure.
Effective Treatment for Sexual Dysfunction
Helps address hypoactive sexual desire disorder (HSDD) and arousal disorders in women.
Supports men with erectile dysfunction, especially when psychological or central causes are involved.
Offers benefits even when traditional PDE5 inhibitors (like Viagra) are less effective or not desired.
Improved Mood and Sexual Confidence
Elevates mood and reduces performance-related anxiety through central melanocortin pathway activation.
Increases feelings of sexual confidence and enjoyment, strengthening intimacy and relationship dynamics.
Promotes a positive feedback loop between desire, arousal, and satisfaction.
Rapid Onset and Targeted Action
Produces noticeable effects on desire and arousal within 30–120 minutes after administration, with effects lasting up to 24–36 hours in many users.
Works centrally in the brain without relying on vascular dilation, making it distinct from other sexual enhancement compounds.
Provides reliable, on-demand support for sexual activity without constant daily dosing.
Broader Emotional and Intimacy Benefits
Enhances emotional connection and intimacy by increasing desire and receptivity to sexual cues.
May support overall sexual satisfaction and relationship quality through improved desire and responsiveness.
Contributes to greater sexual well-being and vitality as part of a holistic approach to intimate health.
PT-141 is a synthetic melanocortin peptide analog of α-MSH, uniquely focused on central nervous system-mediated sexual function.
){kind=link}